Næste

Automatisk afspilning

Novel Agents and Combinations in Hodgkin Lymphoma

0 Visninger • 07/09/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.

For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning